SCHEMBL5372146

SCHEMBL5372146

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3c4ccccc4c(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)c4ccccc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
MAPT P10636 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
MGLL Q99685 1/20 0.39
TAAR1 Q96RJ0 3/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MMP3 P08254 1/20 0.39
BCL2L1 Q07817 1/20 0.39
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14867170 1.00 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL804831 0.98 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL14446780 0.94 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL7601650 0.93 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL762889 0.91 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL14489460 0.90 ACHE (0.39) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL14489365 0.87 ACHE (0.38) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL14867169 0.87 ALOX5 (0.38) ALDH1A1CYP1A2CYP3A4MAPTTDP1
SCHEMBL9971970 0.87 RELA (0.48) ALDH1A1MAPTTDP1L3MBTL1CA1
SCHEMBL22671493 0.86 ACHE (0.36) ALDH1A1CYP1A2CYP3A4MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11778908-B2 Organic electroluminescent devices KUNSHAN GO-VISIONOX OPTO-ELECTRONICS CO., LTD. (CN) 2023-10-03 US disclosed
US-11778908-B2 Organic electroluminescent devices KUNSHAN GO-VISIONOX OPTO-ELECTRONICS CO., LTD. (CN) 2023-10-03 US disclosed
US-20210098713-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 US disclosed
US-9136478-B2 Organic light emitting device and display panel using the same method, terminal, and server for implementing fast playout LG DISPLAY CO., LTD. (KR) 2015-09-15 US disclosed
US-9136478-B2 Organic light emitting device and display panel using the same method, terminal, and server for implementing fast playout LG DISPLAY CO., LTD. (KR) 2015-09-15 US disclosed
US-20130092910-A1 ORGANIC LIGHT EMITTING DEVICE AND DISPLAY PANEL USING THE SAME LG DISPLAY CO., LTD. (KR) 2013-04-18 US disclosed
US-20130092910-A1 ORGANIC LIGHT EMITTING DEVICE AND DISPLAY PANEL USING THE SAME LG DISPLAY CO., LTD. (KR) 2013-04-18 US disclosed
US-20070249866-A1 METHOD FOR PRODUCING AROMATIC AMINO COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249861-A1 METHOD FOR PRODUCING AROMATIC AMINO COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2007-10-25 US disclosed
US-7250532-B2 Method for producing aromatic amino compound IDEMITSU KOSAN CO., LTD. (JP) 2007-07-31 US disclosed
US-20070141393-A1 Amino anthracene compounds in OLED devices EASTMAN KODAK COMPANY 2007-06-21 US disclosed
US-20070141393-A1 Amino anthracene compounds in OLED devices EASTMAN KODAK COMPANY 2007-06-21 US disclosed
US-20060030736-A1 Method for producing aromatic amino compound IDEMITSU KOSAN CO., LTD. (JP) 2006-02-09 US disclosed
US-20040082813-A1 Method for producting aromatic amino compound IDEMITSU KOSAN CO., LTD. (JP) 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249861-A1 METHOD FOR PRODUCING AROMATIC AMINO COMPOUND SLC7A1, SLC43A1, AHR ALDH1A1 455/4885CYP1A2 91/4885CYP3A4 246/4885
US-20060030736-A1 Method for producing aromatic amino compound SLC7A1, SLC43A1, AHR ALDH1A1 447/4885CYP1A2 81/4885CYP3A4 214/4885
US-20040082813-A1 Method for producting aromatic amino compound ADRM1, SLC7A1, AHR ALDH1A1 594/4885CYP1A2 145/4885CYP3A4 269/4885
US-20070249866-A1 METHOD FOR PRODUCING AROMATIC AMINO COMPOUND SLC7A1, SLC43A1, AHR ALDH1A1 455/4885CYP1A2 91/4885CYP3A4 246/4885
US-11778908-B2 Organic electroluminescent devices LAGE3, ELAVL3, ILK ALDH1A1 2482/4885CYP1A2 4548/4885CYP3A4 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.